R ecent studies have demonstrated that amiodarone improves the clinical status and left ventricular function in patients with heart failure (HF). 1, 2 It is noteworthy that amiodarone may reduce total mortality and arrhythmic/sudden death in HF patients or survivors of myocardial infarction. 3 This is in clear contrast to other antiarrhythmia drugs, which have actually increased mortality, as shown by carefully evaluated large randomized trials of high risk patients. 3, 4 These significant clinical benefits have made amiodarone the antiarrhythmic agent of choice in the current treatment of HF patients. 5 Oxidative stress has been shown to play an important role in the pathophysiology of ischemic heart disease 6 and recently in congestive HF. 7, 8 Oxygen radicals can produce deleterious effects on the myocardium, including contractile dysfunction and structural damage. 9 In addition, they can damage vascular endothelial cells. Therefore, oxygen radicalmediated myocardial injury may be involved in the initiation and progression of HF. In addition, it has been suggested that the beneficial effects of carvedilol on HF may be attributable, at least in part, to its antioxidant action. 10, 11 Recent studies have suggested that amiodarone exhibits inhibitory effects against oxygen radical-mediated lipid peroxidation of rat liver mitochondria. 12 Antioxidant activity, if present, may provide additional cardiovascular effects of this drug. However, to our knowledge, no study has examined the radical scavenging action of amiodarone and its protective effects against oxygen radical-mediated cardiac injury in myocytes.
The present study was undertaken to determine whether amiodarone is a free radical scavenger by using in vitro electron paramagnetic resonance (EPR) spectroscopy with spin trap. We also sought to determine whether it is protective against exogenously generated oxygen radical-mediated injury in isolated intact cardiac myocytes. We used isolated myocyte preparations to avoid the confounding systemic effects of amiodarone and to examine its direct effects on myocytes.
Methods

Direct EPR Measurements of Oxygen Radicals
The procedures for EPR with spin trapping agents to directly detect oxygen free radicals were described previously by Mak et al. 13 Briefly, hydroxy free radical (⅐OH) was generated from H 2 O 2 (10 mmol/L) in the presence of an iron redox chelate, Fe 3ϩ -nitrilotriacetate (NTA; 20 mol/L). 9 A spin trap, 5,5Ј-dimethyl-1-pyroline-N-oxide (DMPO; 80 mmol/L), was reacted with ⅐OH in the presence or absence of amiodarone or other test drugs. The formation of the radical spin adduct, DMPO-OH, was monitored with a spectrometer (JES-RE-1X, JEOL Ltd) operating at X-band (9.43 GHz) and a microwave power of 5.0 mW. A range of external magnetic field of 20 mT was swept at a scan rate of 10 mT/min. The amplitude of EPR spin signal, which is proportional to the free radical formation, was used to estimate the scavenging effects of drugs. Quantification of the DMPO signal intensity was performed by comparing the amplitude of the observed signal to a standard Mn 2ϩ /MgO marker.
⅐OH-Mediated Cardiac Myocyte Injury
Cardiac myocytes were isolated from the canine left ventricular free wall as described previously. 14 
Statistical Analysis
Data are expressed as meanϮSEM. An ANOVA with repeated measures was used to compare the time-dependent changes of cell length after the exposure of myocytes to ⅐OH between control and HF. Differences were considered statistically significant at PϽ0.05.
Results
⅐OH Scavenging Action of Amiodarone
The formation of the spin adduct DMPO-OH was evidenced by the appearance of 1:2:2:1 EPR hyperfine splitting pattern characteristic for ⅐OH ( Figure 1A ). As expected, catalase (H 2 O 2 scavenger; 5 U/mL) or mannitol (⅐OH scavenger; 100 mmol/L) showed significant attenuation of EPR spin signals, indicating that EPR signals indeed originated from ⅐OH. Amiodarone inhibited the DMPO-OH signal height in a concentration-dependent manner ( Figure 1B (Figure 2) , which was irreversible even after replacing the bathing media into normal buffer (nϭ8 preparations). ⅐OH-induced hypercontracture was significantly inhibited in the presence of catalase (50 U/mL) or mannitol (100 mmol/L), indicating that hypercontracture was indeed mediated by the generation of ⅐OH radical.
Amiodarone (10 mol/L; nϭ8 preparations) exerted significant (PϽ0.05) protection against the loss of viability (Figure 2 ). In contrast, disopyramide (10 mol/L) and atenolol (10 mol/L) had no such effects.
Discussion
The present study indicated, for the first time, that amiodarone could directly quench ⅐OH radical in vitro and exert a protective effect against ⅐OH radical-mediated cardiac myocyte injury. These effects were not observed in other antiarrhythmia drugs such as disopyramide and atenolol. EPR studies demonstrated that the signal height of DMPO-OH, proportional to the amount of ⅐OH, was decreased in the presence of amiodarone, which indicated that this compound effectively suppressed the formation of the DMPO-OH adduct. Therefore, amiodarone has an ability to directly scavenge ⅐OH radicals. This is in accordance with the recent observation that this drug can inhibit lipid peroxidation in rat liver mitochondrial membranes challenged by an irondependent oxygen radical generating system. 12 The exposure of isolated adult cardiac myocytes to exogenously generated ⅐OH radicals resulted in time-dependent morphological changes, as evidenced by the irreversible hypercontracture, which has been known as an in vitro model of oxidant stress-induced myocyte injury. 9 Amiodarone showed a partial but significant inhibition of oxygen radicalmediated hypercontracture in cardiac myocytes. The protective effects of amiodarone could result from its direct scavenging action on ⅐OH before reaching the cellular sites of injury because cell damage was prevented at a concentration similar to that for inhibition of DMPO-OH adduct formation. Further, even though a direct comparison may not be appropriate, the magnitude of the effects of amiodarone on cellular damage shown in Figure 2 is commensurate with that on ⅐OH formation shown in Figure 1 . However, amiodarone may also interact with the membrane lipids and interrupt the free radical chain reactions, which could contribute to its protection against ⅐OH-induced lipid peroxidation and cellular injury. The present study did not intend to identify the structural requirements for the antioxidant capacity of amiodarone, and thus the mechanisms by which it scavenges oxygen radicals remain to be clarified.
The effective concentration of amiodarone for cardioprotective effects in this study (10 mol/L) appears to be several times higher than its plasma concentration in patients given this drug (0.5 to 2.5 g/mL or 0.7 to 3.5 mol/L). 15 However, this drug is a highly lipophilic compound, 16 suggesting a high affinity of this drug to the plasma membranes. 17 Therefore, it is conceivable that an effective tissue concentration level of amiodarone for exerting the cardioprotective action may be attainable when administered in vivo.
We have shown that amiodarone is an antioxidant and is unique among antiarrhythmia drugs in this respect. Recently, oxidative stress has been implicated in the progression of HF as evidenced by increased oxygen radical generation in failing hearts. 7, 8 Vitamin E, an endogenous antioxidant, has been shown to preserve myocardial structure and function in an animal model of HF. 18 We thus speculate that antioxidant effects of amiodarone might play an important role in the reversibility or prevention of HF. However, the clinical significance of antioxidant action of amiodarone has not been established in this study.
In conclusion, amiodarone protects cardiac myocytes against oxidative stress-mediated injury by scavenging oxygen free radicals. In view of increasing evidence that oxygen radical-mediated myocardial injury is implicated in the pathogenesis of HF, 7, 8 the antioxidant effects of amiodarone, along with its antiarrhythmic effects, would potentially increase its therapeutic value in the treatment of patients with HF.
